Philip Raskin, M.D. Professor Endowed Title Clifton and Betsy Robinson Chair in Biomedical Research School Medical School Department Internal Medicine You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Philip Raskin, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Endocrinology. Both his patient care and clinical research focus on diabetes. Dr. Raskin is the holder of the Clifton and Betsy Robinson Chair in Biomedical Research. Originally from Pittsburgh, Pennsylvania, he holds a bachelor’s degree from Washington & Jefferson College, where he graduated cum laude. After receiving his medical degree from the University of Pittsburgh School of Medicine, Dr. Raskin remained there to complete his residency in internal medicine. He then performed a fellowship in endocrinology, diabetes, and metabolism at UT Southwestern. Board certified in endocrinology, diabetes, and metabolism, he joined the UT Southwestern faculty in 1973. Currently, Dr. Raskin is the Director of the Diabetes Clinic at Parkland Hospital. He is the Principal Investigator in four NIH-funded multicenter diabetes trials: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC), TrialNet, The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study), and Vitamin D to Prevent Type 2 Diabetes (D2d Study). He served as editor of the Journal of Diabetes and Its Complications from 1990 to 2011 and is also a past editor of Clinical Diabetes. Dr. Raskin is widely published in peer-reviewed journals including the New England Journal of Medicine, The Journal of Clinical Investigation, Diabetes, Diabetes Care, the Annals of Internal Medicine, and the Journal of Diabetes and Its Complications. He also has authored numerous chapters in clinical textbooks. He is also an active member of several professional organizations, including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American Society of Clinical Investigation, Endocrine Society, Society for Clinical Trials, Southern Society for Clinical Investigation, Texas Medical Association, and Dallas County Medical Society. Education Medical School University of Pittsburgh School of Medicine (1966) Internship University of Pittsburgh Medical Center Montefiore/Presbyterian (1967), Internal Medicine Residency University of Pittsburgh Medical Center Montefiore/Presbyterian (1968), Internal Medicine Fellowship Parkland Health & Hospital System (1971), Endocrinology & Metabolism Research Interest Diabetes Diabetic Complications Hypertension Lipid Disorders New Diabetes Therapies Publications Featured Publications Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs insulin glargine in the US J A Ray, W J Valentine, S Roze, L Nicklasson, D Cobden, P Raskin, A Garber, A J Palmer Diabetes, Obesity, and Metabolism January 2007 9(1) 103-113 Effects of multiple daily insulin injections on peripheral glucose disposal in Latin Americans with type 2 diabetes mellitus L Aviles-Santa, K Salinas, B Adams-Huet, P Raskin Journal if Investigative Medicine January 2007 55(1) 11-17 Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted I Lingvay, P F Kaloyanova, B Adams-Huet, P Raskin Journal of Investigative Medicine 2007 55(2) 62-68 Increased erythrocyte aldosed reductase activity in type 1 diabetic patients Hamada Y, Kito R, and Raskin P Diabetic Medicine 1991 8 226-231 Independence of cholesterol and fatty acid biosynthesis from cyclic AMP concentration in the perfused rat liver. Raskin P, McGarry JD, Foster DW J. Biological Chemistry 1974 249 6029 Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes I Lingvay, P Raskin, L S Szezepaniak Journal of Diabetes and Its Complications May 2007 21(3) 137-142 Basal insulin or premix analogue therapy in type 2 diabetes patients P Raskin, P A Hollander, A Lewin, R A Gabbay, B Bopde, B Garber, INITIATE Study Group European Journal of Internal Medicine January 2007 18 56-62 Weight gain in type 2 diabetes mellitus A N Jacob, K Salinas, B Adams-Huet, P Raskin Diabetes, Obesity and Metabolism 2007 9 386-393 Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues M Brod, D Cobden, M Lammert, D Bushnell, P Raskin Health and Quality of Life Outcomes 2007 5 8 Lung function changes related to diabetes mellitus C W Hsia, P Raskin Diabetes Technology & Therapeutics 2007 9(1) S73-S82 Results 1-10 of 10 1 Honors & Awards Hench AwardUniversity of Pittsburgh (2011) Alumni Award for AchievementWashington & Jefferson College (2007) J. Denis McGarry AwardAmerican Diabetes Association (2004) FellowAmerican College of Endocrinology (1995) Charles H. Best Award for Distinguished ServiceAmerican Diabetes Association (1994) Citation of MeritAmerican Physician Fellowship for Medicine in Israel (1991) Alpha Omega Alpha (1965) Owens FellowshipUniversity of Pittsburgh (1965) The Best Doctors In American1992-1993, 1994-1995, 2001-2002, 2005-2006 (0) Professional Associations/Affiliations American College of Endocrinology American College of Physicians American Diabetes Association American Federation for Clinical Research American Heart Association American Society of Clinical Investigation Dallas County Medical Society Endocrine Society Society for Clinical Trials Southern Society for Clinical Investigation Texas Medical Association
